CisplatinAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsPlatinumDrug Resistance, NeoplasmDrug Administration ScheduleCombined Modality TherapyLung NeoplasmsEtoposideOvarian NeoplasmsDeoxycytidineTreatment OutcomeFluorouracilVinblastineDNA AdductsPaclitaxelCell Line, TumorHead and Neck NeoplasmsCarcinoma, Squamous CellCarboplatinIfosfamideApoptosisVomitingDose-Response Relationship, DrugSurvival AnalysisDrug Screening Assays, AntitumorDrug SynergismCarcinoma, Non-Small-Cell LungInfusions, IntravenousDoxorubicinTaxoidsTumor Cells, CulturedDisease-Free SurvivalLeukopeniaSurvival RateCell SurvivalTesticular NeoplasmsNauseaMitomycinAdenocarcinomaNeoplasm StagingCamptothecinDNA DamageTime FactorsVindesineCarcinoma, Small CellOxonic AcidNeutropeniaBleomycinAntineoplastic Agents, PhytogenicStomach NeoplasmsTegafurDNA RepairNeoplasms, Germ Cell and EmbryonalNeoplasm Recurrence, LocalChemotherapy, AdjuvantDrug EvaluationDrug ResistanceNeoplasmsGerminomaEsophageal NeoplasmsMesotheliomaMice, NudeEpirubicinAntiemeticsMaximum Tolerated DoseDrug InteractionsTumor Suppressor Protein p53ThrombocytopeniaCarcinomaKidneyPleural NeoplasmsUrologic NeoplasmsAntimetabolites, AntineoplasticDose FractionationRadiation-Sensitizing AgentsOndansetronCyclophosphamideGene Expression Regulation, NeoplasticCell ProliferationNeoadjuvant TherapyGuanineInduction ChemotherapyRemission InductionAmifostineUterine Cervical NeoplasmsAntineoplastic Agents, AlkylatingMethotrexateRadiotherapy DosagePlatinum CompoundsSignal TransductionGlutathioneFollow-Up StudiesHematologic DiseasesOsteosarcomaBlotting, WesternInfusions, Intra-ArterialFeasibility StudiesCell CycleThiosulfates